US Patent 7115272 Compositions and methods for WT1 specific immunotherapy
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Alexander Gaiger0
Martin A. Cheever0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+382 characters)
Article
Patent abstract
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise a WT1 polypeptide comprising an immunogenic portion of WT1, wherein said WT1 polypeptide comprises the polypeptide of SEQ ID NO:144. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07115272 Compositions and methods for WT1 specific immunotherapy US Patent 7115272 Compositions and methods for WT1 specific immunotherapy
Infobox
Patent Number
07115272
Patent Number
7115272
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07115272 Compositions and methods for WT1 specific immunotherapy
Infobox
Is a
Patent jurisdiction
Patent number
07115272
Date of patent
October 3, 2006
Patent application number
09684361
Date Filed
October 6, 2000
Patent primary examiner
Find more entities like US Patent 7115272 Compositions and methods for WT1 specific immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.